3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: March 3, 2011
Period of Report: February 28, 2011
Accession Number: 0001325812-11-000003

View Document ↗ View on SEC.gov ↗